In vitro activities of five new antimicrobial agents against Brucella melitensis
- 11 June 1999
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 12 (2) , 185-186
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- In vitro activities in new oxazolidinone antimicrobial agents against enterococciAntimicrobial Agents and Chemotherapy, 1996
- Antibacterial Activity of Quinupristin/DalfopristinDrugs, 1996
- StreptograminsDrugs, 1996
- BrucellosisInternational Journal of Antimicrobial Agents, 1995
- Comparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1994
- Lack of effective bactericidal activity of new quinolones against Brucella sppAntimicrobial Agents and Chemotherapy, 1991
- Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational studyJournal of Antimicrobial Chemotherapy, 1989
- Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1987
- MupirocinDrugs, 1986
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986